In Depth
Also in this section
How Pfizer management outplayed activist investor Starboard
Trump 2.0 spells global change in pharmaceutical industry
Flu vaccine strategy on the line as new US leaders anticipated to take charge
Lilly’s £279m bet aims to boost UK life sciences sector
PrEP therapies offer new hope in HIV preventive landscape as vaccine failures amas